1
Enquiry period
with 12.09.2023 16:48
to 18.09.2023 10:00
2
Bidding period
with 18.09.2023 10:00
to 21.09.2023 14:00
3
Auction
22.09.2023 15:00
4
Evaluation

5
Contract

Status Evaluation
Estimated value without VAT 488 646,67 MDL
Period of clarifications: 12 Sep 2023, 16:48 - 18 Sep 2023, 10:00
Submission of proposals: 18 Sep 2023, 10:00 - 21 Sep 2023, 14:00

Supplier technical support:

(+373) 79999801

“Achiziţionarea medicamentelor pentru tratamentul pacienților cu maladia β Talasemie întru scopul realizării Programului Național ,,Combatarea maladiilor rare” pentru anul 2024”
Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Full name
Macari Doina
Contact phone
+37322222490
Purchase data
Date created
12 Sep 2023, 16:35
Date modified
12 Sep 2023, 16:48
Achizitii.md ID
21092073
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Request price offers (goods)
Award criteria
The lowest price
Funding sources
List of lots
Deferasiroxum 180 mg
Budget: 488646.67 MDL
Active
Documents of the procurement procedure
Scrisoare de garantie bancara_Model
Bidding Documents
Scrisoare de garantie bancara_Model
12.09.23 16:48
Propunerea tehnică
Technical Specifications
Propunerea tehnică
12.09.23 16:48
Propunerea financiară
Technical Specifications
Propunerea financiară
12.09.23 16:48
Anunt de participare T.signed
Bidding Documents
Anunt de participare T.signed
12.09.23 16:48
contract model PN
Bidding Documents
contract model PN
12.09.23 16:48
Documentatia standard T.signed
Bidding Documents
Documentatia standard T.signed
12.09.23 16:48
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declaratie privind valabilitatea ofertei_Model
12.09.23 16:48
DUAE Model
Bidding Documents
DUAE Model
12.09.23 16:48
Declaratie beneficiari efectivi_Model
Bidding Documents
Declaratie beneficiari efectivi_Model
12.09.23 16:48
Cerere de participare_Model
Bidding Documents
Cerere de participare_Model
12.09.23 16:48
Only authorized platform users may ask questions during the clarification period.